Rubicon Research
RUBICONNSE

Rubicon Research

₹898.900.00 (0.00%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
873.00
Today’s high
913.10
52 week low
570.75
52 week high
913.10
Open price
888.00
Previous close
898.90
Live volume
--
Lower circuit
719.15
Upper circuit
1,078.65

Fundamentals

Market Cap
₹14,779Cr
ROE
26.49%
P/E Ratio(TTM)
71.65
EPS(TTM)
12.52
P/B Ratio
12.88
Dividend Yield
0.00%
Industry P/E
32.46
Book Value
69.66
Debt to Equity
0.88
Face Value
1

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Rubicon Research Limited is a pharmaceutical company specializing in drug delivery technologies and developing complex formulations.;
CEO/MD
Parag Suganchand Sancheti
Founded in
2000
NSE symbol
RUBICON

Shareholding Pattern

Jul '24
Sep '25
Oct '25
Dec '25
Promoters
59.99%
Retail And Others
18.56%
Foreign Institutions
12.00%
Mutual Funds
6.61%
Other Domestic Institutions
2.83%

Mutual Funds Invested (1)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹655.70
0.00 (--)
L
    H
    16,215.8329.733.79
    ₹910.90
    0.00 (--)
    L
      H
      14,521.7933.812.2
      ₹1,069.65
      0.00 (--)
      L
        H
        13,091.6724.084.34
        Concord BiotechCONCORDBIO
        ₹1,081.70
        0.00 (--)
        L
          H
          11,311.6336.366.19
          Livesquawk
          Motilal Oswal raises Rubicon Research's TP to ₹955 citing Arinna Lifescience acquisition. Acquisition aids CNS therapy entry, US pipeline leverage, and P/E rerating to 37x.
          2026
          3
          Feb
          Quarterly Result
          Release date
          2025
          13
          Nov
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks